In 2003, surviving sepsis campaign gave a precise definition for sepsis^\[[@b1-jtim-2015-0010]\]^. Diagnostic criteria for sepsis in the elderly is the same as applied to general population. This includes documented or suspected infection plus change in any hemodynamic or hematological variable. These may include change in vitals including temperature, respiratory rate, blood pressure, and tachycardia. Markers of cellular immunity may be altered that may manifest as increased white blood cells (WBCs), decreased WBCs, increased C-reactive protein, or increased procalcitonin (PCT) level. There may be signs of organ dysfunction that may manifest as hypoxia, renal dysfunction, ileus, increased cardiac index, and hyperbilirubinemia. There may be signs of decreased tissue perfusion that may manifest as increased lactate or ileus. Severe sepsis refers to sepsis with organ dysfunction requiring support. Thus, the term sepsis and severe sepsis are often used interchangeably. Septic shock is defined as sepsis-induced hypotension or hyperlactatemia persisting despite adequate fluid resuscitation. Multiple organ dysfunction syndrome (MODS) refers to progressive organ dysfunction in an acutely ill patient needing critical care support.

METHODS OF LITERATURE SEARCH
============================

The review was performed after searching the full text and abstracts from the literature in Pubmed, HINARI, Scopus, Science Direct, Ovid MEDLINE, and Google scholar and the following keywords combinations were used: Sepsis, CHF, elderly, CKD, Antibiotic resistance. Various text books of critical care medicine and anesthesiology as well as international anesthesia journals were also searched for full text articles related to management of sepsis in the elderly.

EPIDEMIOLOGY: INCIDENCE AND RISK FACTORS
========================================

The incidence of sepsis is disproportionately increased in older adult patients and age is an independent predictor of mortality due to sepsis^\[[@b2-jtim-2015-0010]\]^. The cytochrome (CYH) and p-gp system involved in drug metabolism also slows down with aging and could potentially accentuate drug toxicities and delirium seen in critical care settings^\[[@b3-jtim-2015-0010],[@b4-jtim-2015-0010]\]^. Case fatality of pneumococcal bacteremia may be as high as 60% in the elderly demented patients^\[[@b5-jtim-2015-0010]\]^. In the late 1970s, it was estimated that 164,000 cases of sepsis occurred in the USA each year^\[[@b6-jtim-2015-0010]\]^. Another population-based recent analysis showed increased incidence of sepsis and septic shock from 13 to 78 cases per 100,000 from 1998 to 2001^\[[@b7-jtim-2015-0010]\]^. In an observational cohort study by stiermaier *et al.*^\[[@b8-jtim-2015-0010]\]^, 28-day mortality in patients with sepsis was found to be 29.5% and increased to 55.4% in 3 years after discharge from the hospital. The elderly are more predisposed to nosocomial infections and physical deconditioning when admitted to the acute care hospitals^\[[@b9-jtim-2015-0010]\]^. The elderly hospitalized patients with dementia are at high risk for urinary tract infection (UTI), pressure sores, pneumonia, and delirium^\[[@b10-jtim-2015-0010],[@b11-jtim-2015-0010]\]^. This puts them at risk for bacteremia, which could accentuate mortality. The severity of disease appears to be increasing^\[[@b12-jtim-2015-0010]\]^. But mortality rate appears to have decreased in severe sepsis and septic shock after adjusting for age and comorbidities. This is due to increased adherence to severe sepsis and septic shock bundle^\[[@b6-jtim-2015-0010],[@b13-jtim-2015-0010]\]^.

The elderly patients, especially women who have multiple comorbidities and also those with severe congestive heart failure (CHF) (especially right heart failure) are at high risk for sepsis^\[[@b14-jtim-2015-0010]\]^. Also, the elderly with dementia have increased incidence of UTI, pressure sores, pneumonia, trauma, and delirium, which complicates the clinical scenario^\[[@b10-jtim-2015-0010],[@b15-jtim-2015-0010]\]^. Pneumonia and indwelling catheter-related sepsis are the most common causes of secondary bacteremia^\[[@b16-jtim-2015-0010]\]^.

Diabetes, because of its high prevalence in the elderly, is the most common risk factor for sepsis. It also results in increased risk of nosocomial sepsis^\[[@b17-jtim-2015-0010]\]^. Pneumonia may predispose to severe sepsis in roughly half the patients and about 5% may go into septic shock^\[[@b18-jtim-2015-0010]\]^. Traveling may be a risk factor for sepsis irrespective of age and diarrhea is usually the most common cause when traveling to Asia^\[[@b19-jtim-2015-0010]\]^.

PATHOPHYSIOLOGICAL BASIS OF CLINICAL SYMPTOMATOLOGY
===================================================

Cellular immunity in the elderly is hyperactive and humoral immunity is depressed^\[[@b20-jtim-2015-0010],[@b21-jtim-2015-0010]\]^. So the elderly with sepsis may not show classical signs of sepsis, especially fever secondary to compromised humoral immunity^\[[@b18-jtim-2015-0010]\]^. Leukemoid reaction (LR) may be seen in sepsis and carries a grave prognosis in the elderly^\[[@b22-jtim-2015-0010]\]^. It is the comorbidities that often define the clinical presentation of the sepsis in the elderly^\[[@b23-jtim-2015-0010]\]^.

PROGNOSTIC FACTORS
==================

Astute prognostication prior to aggressive management of the elderly in the critical care settings may decrease patient discomfort and reduce cost^\[[@b24-jtim-2015-0010]\]^. Prognostic factors are, especially important in the emergency and elective perioperative settings. According to American society of anesthesiologists, the most important prognosticators are functional status, sepsis, and age. In a study by Al-Temini *et al.,* for the elderly aged more than 90 years with septic shock and poor preoperative functionality, the chances of survival were less than 10%^\[[@b25-jtim-2015-0010]\]^. In the postoperative settings, the most common cause of death is CHF, sepsis, and multi-organ failure^\[[@b26-jtim-2015-0010]\]^. In a study by Lemay *et al,* the predictors of long-term mortality included CHF, PAD, DM, and mechanical ventilation^\[[@b17-jtim-2015-0010]\]^. Age, comorbidities, length of stay (LOS), diagnosis of sepsis or malignancy are predictors of mortality at 6 months in the elderly discharged from the hospital^\[[@b27-jtim-2015-0010]\]^.

Comorbidities predict and define the prognosis. The site of infection in patients with sepsis may be an important determinant of outcome, with skin infections generally being associated with the lowest mortality rates^\[[@b14-jtim-2015-0010]\]^. Mortality in emergency department sepsis (MEDS) score and PCT increases the prognostication and risk stratification in the elderly with sepsis^\[[@b28-jtim-2015-0010]--[@b32-jtim-2015-0010]\]^. MEDS is based on cardiorespiratory, neurological, and hematological variables. Also, high points are added if there is an underlying terminal illness or the patient is institutionalized. MEDS scoring system helps in prediction of mortality in sepsis and could potentially help in astute prognostication and withholding treatment when clinically futile^\[[@b30-jtim-2015-0010],[@b33-jtim-2015-0010]--[@b36-jtim-2015-0010]\]^.

CLINICAL CONUNDRUMS AND CHALLENGES IN MANAGEMENT OF SEPSIS
==========================================================

Substantial health care resources are spent in the terminal stages of life. Many of the treatment modalities are rather ineffective and costs huge amount of healthcare dollars. Majority of the patients with sepsis are the elderly and treated in the non-ICU settings^\[[@b8-jtim-2015-0010]\]^. The surviving sepsis campaign emphasizes two bundles of care. The initial bundle is focused on resuscitation to restore the impaired tissue perfusion and oxygenation^\[[@b37-jtim-2015-0010]\]^. This is to be accomplished in the first 6 hours of presentation. The second bundle is focused on further management and is to be accomplished in the ICU. Early diagnosis and goal-directed therapy is the goal^\[[@b38-jtim-2015-0010],[@b39-jtim-2015-0010]\]^. The resuscitation requires the use of fluids and pressors. The kind of fluids and pressors remain a matter of debate. Protocolized approach in the implementation of these bundles is emphasized^\[[@b40-jtim-2015-0010]\]^. Use of ventilatory weaning and glycemic control protocols are classified as grade 1A recommendations in the surviving sepsis campaign protocols^\[[@b40-jtim-2015-0010]\]^.

Although excellent, the surviving sepsis campaign guidelines are not very specific in the elderly with severe sepsis and septic shock. The elderly are very fragile and interference of one-body system may lead to dysfunction of other systems. Clinical conundrums that complicate clinical course of sepsis in the elderly need to be addressed (Ref [Fig. 1](#f1-jtim-2015-0010){ref-type="fig"}).

The most common cause of hospitalization in the elderly in high income countries is CHF^\[[@b14-jtim-2015-0010]\]^. In a study by Alon *et al.,* 38% of patients admitted for CHF had underlying sepsis with respiratory sepsis being most common. Urinary, skin, and soft tissue infections were other common entities^\[[@b14-jtim-2015-0010]\]^. Atrial fibrillation (AF) is also concomitantly present in patients with CHF. The tachycardia associated with sepsis may be wrongly attributed to AF and thereby delay the diagnosis and management of sepsis in the elderly. In a retrospective study by Walkey *et al.,* age was one of the prime determinant of new onset and prevalence of AF in the elderly population. AF may be an underlying comorbidity or may be a manifestation of sepsis. Rate control and therapeutic anticoagulation potentially gets complicated with underlying sepsis. Anticoagulation with Coumadin is usually complicated because of the use of CYH inhibiting or stimulating medications in critical care settings. Also, if new oral anticoagulants are being used, their anticoagulant effect may be compromised or increased depending on drug interactions or changing renal function^\[[@b3-jtim-2015-0010]\]^. In these settings, it is better to use either unfractionated heparin or enoxaparin until the patient is stable. The surviving sepsis campaign offers no specific guidelines in the matter.

Hemodynamic changes in sepsis may predispose the elderly to acute kidney injury (AKI), especially if they have underlying chronic kidney disease (CKD)^\[[@b41-jtim-2015-0010]\]^. Most common renal manifestation of sepsis is AKI^\[[@b42-jtim-2015-0010]\]^. In a study by Romao *et al.,* sepsis in itself or in combination with other factors such as hypotension and nephrotoxic medications was responsible for AKI in the elderly^\[[@b43-jtim-2015-0010]\]^. These are potentially correctable in majority of the cases^\[[@b44-jtim-2015-0010]\]^. Sepsis-related AKI has been associated with increased mortality^\[[@b45-jtim-2015-0010]\]^. AKI that happens more than a week later into the postoperative period is usually a sign of sepsis in the elderly patients^\[[@b46-jtim-2015-0010]\]^. CHF and CKD are usually coexistent in the elderly population thus exacerbating the electrolyte imbalance. Fluid resuscitation in this population is critical but needs to be titrated carefully. Superadded insult of AKI needs to be avoided. Nephrotoxic agents should be avoided as the elderly in critical care settings are at high risk for AKI^\[[@b41-jtim-2015-0010],[@b47-jtim-2015-0010]\]^. Failure to aggressively try to restore perfusion early may also be associated with mortality. On the other hand, aggressive hydration is likely to lead to CHF and respiratory failure in the elderly who often have underlying CHF. Although critical, surviving sepsis campaign offers no specific guidelines for renal protection.

Delirium and dementia are often made worse in the critical care settings. Polypharmacy and potentially inappropriate medication use is one of the major contributor to delirium in the hospitalized the elderly^\[[@b48-jtim-2015-0010]\]^. The elderly are more predisposed to depression and alcohol abuse. Delirium may be a manifestation of underlying sepsis in the elderly, especially when the patient is in long-term care setting. This may present as a diagnostic challenge to the clinician^\[[@b38-jtim-2015-0010],[@b49-jtim-2015-0010]--[@b51-jtim-2015-0010]\]^. The clinical picture of delirium may be complicated by the use of sedative drug use, post-operative state, and ambulatory dysfunction^\[[@b48-jtim-2015-0010],[@b52-jtim-2015-0010],[@b53-jtim-2015-0010]\]^. Often, they are on polypharmacy, which opens the door for drug-induced delirium^\[[@b54-jtim-2015-0010]\]^. This may further pose a challenge in management of sepsis. Often, diagnosis of sepsis may be missed because of the masking effect of the comorbidities^\[[@b26-jtim-2015-0010],[@b41-jtim-2015-0010]\]^. The elderly with delirium have more complications related to hospitalization than patients without delirium^\[[@b10-jtim-2015-0010],[@b55-jtim-2015-0010]\]^. Delirium predisposes the elderly to high risk for peripheral muscle wasting and consequent ambulatory dysfunction^\[[@b56-jtim-2015-0010]\]^. This reinforces the need to minimize polypharmacy and potentially inappropriate medication use in the elderly. Again, the surviving sepsis campaign surprisingly falls short on guidelines on this aspect of sepsis management.

Hypoglycemia is commonly seen in the elderly with CKD and sepsis and usually indicates a bad prognosis^\[[@b48-jtim-2015-0010],[@b57-jtim-2015-0010]--[@b59-jtim-2015-0010]\]^. This may be seen in both diabetics and non diabetics^\[[@b48-jtim-2015-0010],[@b57-jtim-2015-0010],[@b60-jtim-2015-0010]--[@b62-jtim-2015-0010]\]^. This is due to decreased metabolism of insulin and diminished glycogen reserves in the body. Intensive insulin regime should be discouraged in the critical care settings with target glucose levels less than 180 but more than 120 mg%. Malnutrition in the hospitalized elderly could contribute to hypoglycemia and may be related to short-term mortality^\[[@b63-jtim-2015-0010]--[@b64-jtim-2015-0010]\]^. Enteral feeding should be started within 48 hours when feasible. Total parenteral (TPN) feeding could be considered when enteral feeding is not possible. Structured lipid emulsions for TPN in sepsis are considered more effective^\[[@b65-jtim-2015-0010]\]^. Anemia of chronic disease is also a result of sepsis and manifests secondary to altered iron metabolism^\[[@b66-jtim-2015-0010]\]^. Underlying sick euthyroid syndrome indicates a worse outcome^\[[@b23-jtim-2015-0010],[@b67-jtim-2015-0010]\]^.

Ambulatory dysfunction is another clinical conundrum, which could potentially complicate the treatment and increase the length of stay. It further predisposes to nosocomial infections. More often than not, they need inpatient rehabilitation prior to discharge to home. So physical therapy and early ambulation needs to be prioritized^\[[@b27-jtim-2015-0010]\]^.

The clinical conundrum of antibiotic resistance has significant impact on morbidity and mortality in the elderly and needs to be considered when starting antibiotics in the elderly^\[[@b68-jtim-2015-0010]\]^. In September 2013, antibiotic resistance report by Center for Disease Control and Prevention (CDC) reported that majority of antibiotic resistance-related deaths occur in healthcare settings like nursing homes, long-term acute care or acute care hospitals where bulk of the patients are elderly and exposed to repeated antibiotics ([Table 1](#t1-jtim-2015-0010){ref-type="table"}). As per CDC, about 2 million patients are sickened each year in USA by infections that are resistant to antibiotics. About 23,000 people die each year secondary to antibiotic resistance and failure of treatment. In 2008, Roberts *et al.,* studied the cost attributable to antibiotic resistance in 188 hospitalized patients. By conservative estimates, the cost was estimated to be 13.35 million dollars^\[[@b69-jtim-2015-0010]\]^.

The CDC has defined three levels of threats posed by antibiotic resistance. The threats have been classified as urgent, serious, or concerning depending on the urgency and gravity of the situation ([Tab. 1](#t1-jtim-2015-0010){ref-type="table"}). In the urgent category is *Clostridium difficile*-associated diarrhea (CDAD), which is directly linked to widespread and inappropriate antibiotic use in the elderly population^\[[@b70-jtim-2015-0010]\]^. There are not many antimicrobial agents available to treat CDAD and the prevalence of CDAD continues to increase. Fidaxomicin is a relatively new macrolide to treat the CDAD. It is considered a first-line drug in the treatment of recurrent CDAD. It has minimal effect on the gut microflora and persists in the bowels for at least 21 days^\[[@b71-jtim-2015-0010]--[@b73-jtim-2015-0010]\]^. It is associated with fewer recurrences and sustained clinical cure^\[[@b74-jtim-2015-0010]--[@b78-jtim-2015-0010]\]^. It has favorable pharmacokinetics and minimal drug interactions. But it needs to be used with caution to prevent drug resistance. Methicillin-resistant *Staphylococcus aureus* (MRSA) and drug-resistant streptococcal pneumonia figure in the serious category in antibiotic resistance threat report by the CDC. MRSA causes 80,000 cases of severe infections each year and 11,000 deaths occur each year in USA. Although these microbes commonly afflict the elderly, they are not classified as urgent due to more antibiotics available for clinical use in this category. Multidrug-resistant (MDR) pseudomonas also figures in the list of serious threat. Antibiotics may be used with cynicism at times as excess may not always be good. Dual antibiotics with quinolones may not be needed in all patients with pseudomonas pneumonia^\[[@b79-jtim-2015-0010]\]^.

On the other hand, inadequate antibiotics may be associated with increased mortality in the elderly^\[[@b80-jtim-2015-0010],[@b81-jtim-2015-0010]\]^. Sepsis due to nosocomial pathogens has a higher mortality than sepsis due to community-acquired pathogens. With HCAI, there are increased chances of inadequate antibiotic use. In contrast, prior antibiotic therapy may be associated with increased mortality, at least among patients with Gram-negative sepsis. With high incidence of readmissions to the hospital, there is increasing incidence of HCAI and increasing microbial resistance^\[[@b81-jtim-2015-0010]\]^. This is because patients who have received prior antibiotic therapy are more likely to have higher rates of antibiotic resistance, making it less likely that appropriate antibiotic therapy will be chosen empirically. PCT-guided antibiotics have shown to decrease the duration of antibiotics^\[[@b13-jtim-2015-0010]\]^. There is increased resistance to B lactams for pneumococcus. Increase in PCT \>9 suggests severe sepsis and increase in mortality and morbidity. PCT has also been used for severity classification and treatment decisions in sepsis^\[[@b13-jtim-2015-0010],[@b30-jtim-2015-0010]\]^.

CDC is working on modules to track the antibiotic resistance in hospital labs. It would be compiled in national data base and made available to local and state authorities that could track the data further and make corrective steps to minimize antibiotic resistance. Also, this needs to go hand in hand with antibiotic stewardship, which ensures appropriate use of antibiotics. CDC estimates that more than half the people who get antibiotics do not really need it. Antibiotic development has not kept pace with rapidity with which antibiotic resistance has been developing and that is a reason for concern. Future research should focus not only on developing antibiotics but also biological therapy for infectious diseases. The avenue to treat bacterial infections with biologic approach has been a success story in some areas. Fecal transplant to treat recurrent CDAD holds promise^\[[@b82-jtim-2015-0010]\]^. It needs some improvisation for wide acceptance by the physicians and the patient population.

Vaccine for pneumococcal pneumonia has been a success story. It has shown to reduce hospitalization for pneumonia by reducing the incidence of invasive disease^\[[@b83-jtim-2015-0010]\]^. High potency influenza vaccine has shown promise in the elderly in prevention of influenza^\[[@b84-jtim-2015-0010]\]^. Vaccines for *S. aureus* are not effective so far. Continued research is needed in this direction to lower the burden of infectious disease.

CONCLUSION
==========

Diagnosis and treatment of sepsis in the elderly is a rigmarole of complex clinical conundrums. The presentation is often atypical. They frequently have multiple comorbidities, which define the presentation and prognosis of sepsis in the elderly. The need of the hour are guidelines that emphasize the management of clinical conundrums associated with sepsis in the elderly. This would not only be cost effective but improve the morbidity, mortality, and quality of life in the elderly.
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###### 

Antimicrobial resistance threats in USA: 2013

  ------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  URGENT       *C. difficile*, carbepenem-resistant enteriobacteriacea, drug-resistant *Neisseria gonorrhea*
               
  SERIOUS      Multidrug-resistant acinetobacter, drug-resistant campylobacter, fluconazole-resistant candida, extended spectrum beta lactamase, vancomycin-resistant enterococcus, MDR pseudomonas, drug-resistant non-typhi salmonella, drug-resistant *salmonella typhi*, MRSA, drug-resistant streptococcal pneumonia, drug-resistant tuberculosis
  CONCERNING   Vancomycin-resistant *S. aureus*, erythromycin-resistant group A Strep, clindamycin-resistant group B streptococcus.
  ------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Adapted from September 2013 CDC report on antimicrobial resistance.
